Johnson & Johnson Enterprise Business Review
Fueled by breakthrough science and transformational technology, Johnson & Johnson is advancing the future of health care. With leading businesses in Innovative Medicine and MedTech, the company is focused on bringing differentiated innovation to patients, strengthening its portfolio, fortifying its pipeline and creating sustainable long-term value.
Learn more about Johnson & Johnson’s portfolio across six key focus areas: Oncology, Immunology, Neuroscience, Cardiovascular, Surgery and Vision.
Learn more about Johnson & Johnson’s portfolio across six key focus areas: Oncology, Immunology, Neuroscience, Cardiovascular, Surgery and Vision.
Register for Johnson & Johnson’s Enterprise Business Review
Tuesday, December 8, 2026
Innovating in Health&Care
-
-
Understanding the importance of biologics
Biologics, a class of medications derived from living organisms, treat a range of conditions including immune-mediated diseases and cancer. Learn how Johnson & Johnson is innovating in biologics to improve treatment options for people around the world.
-
What is cardiac ablation?
Learn how Johnson & Johnson is innovating to help treat the millions of people who are living with atrial fibrillation and other conditions that cause an irregular heartbeat. -
Striving for a cure for multiple myeloma
Jordan Schecter, M.D., leader of Johnson & Johnson’s end-to-end development strategy for multiple myeloma, shares insight on the evolving treatment landscape of this rare blood cancer. -
-
5 ways Johnson & Johnson is innovating in medicines and therapies
From rare diseases to all-too-common cancers, Johnson & Johnson is on a mission to improve treatment options for people around the globe. Learn more about how the company is working to create new therapies for IBD, lung cancer, major depressive disorder, bladder cancer, myasthenia gravis and more. -
“Reimagining what life with schizophrenia could look like”
Johnson & Johnson’s Leonardo Diaz, M.D., addresses common misconceptions about schizophrenia, the critical importance of preventing relapse and why there’s so much optimism about treatments. -
“We are in a golden age of cataract surgery”
Once considered a straightforward procedure to restore cloudy vision, cataract surgery has evolved into one of the most technologically advanced—and personalized—operations in modern medicine. Learn how Johnson & Johnson’s 25-year history of innovation is helping eye surgeons meet the moment.
-
A behind-the-scenes look at how Johnson & Johnson manufactures and delivers CAR-T cell therapy for multiple myeloma
Transforming cancer patients’ own cells into a targeted treatment is a complex and nuanced process. Jessica Torfs, director of Global CAR-T Supply Chain at Johnson & Johnson, explains what it takes to deliver this cutting-edge personalized therapy. -
When depression improves but patients still grapple with symptoms
Only one in three people with major depressive disorder achieves remission after their first antidepressant, leaving many to continue to experience life-impacting symptoms such as disrupted sleep, changes in weight and appetite and trouble concentrating. Learn why Johnson & Johnson is working to help more patients achieve remission. -
“Our goal is a solution for every bladder cancer patient”
Meet Christopher Cutie, M.D., the Johnson & Johnson scientist who’s helping change the treatment landscape for people with bladder cancer, the tenth most common cancer in the world.
Our Innovative Medicine and MedTech focus areas
-
Find information about clinical trials
Read moreYou are now leaving jnj.com.
This link will take you to a website outside of Johnson & Johnson, which is governed by its own privacy policy and terms of use. Click continue to proceed.
You are now leaving jnj.com.
This link will take you to a website outside of Johnson & Johnson, which is governed by its own privacy policy and terms of use. Click continue to proceed.
-
Learn about our development pipeline
Read moreYou are now leaving jnj.com.
This link will take you to a different Johnson & Johnson website, where different laws and regulations may apply.
You are now leaving jnj.com.
This link will take you to a different Johnson & Johnson website, where different laws and regulations may apply.